Short Interest in Pluri Inc. (NASDAQ:PLUR) Declines By 62.3%

by · The Cerbat Gem

Pluri Inc. (NASDAQ:PLUR – Get Free Report) saw a significant decrease in short interest in October. As of October 15th, there was short interest totalling 2,300 shares, a decrease of 62.3% from the September 30th total of 6,100 shares. Based on an average daily trading volume, of 11,500 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the shares of the stock are sold short.

Pluri Price Performance

Shares of NASDAQ:PLUR traded up $0.05 during trading on Friday, hitting $4.37. 11,882 shares of the company were exchanged, compared to its average volume of 15,722. The business’s 50 day moving average is $5.22 and its 200-day moving average is $5.49. The company has a market capitalization of $23.90 million, a P/E ratio of -0.74 and a beta of 1.60. The company has a quick ratio of 6.98, a current ratio of 6.98 and a debt-to-equity ratio of 4.44. Pluri has a 1-year low of $3.45 and a 1-year high of $8.48.

Pluri (NASDAQ:PLUR – Get Free Report) last announced its quarterly earnings results on Wednesday, September 18th. The company reported ($2.98) earnings per share (EPS) for the quarter. The company had revenue of $0.26 million for the quarter. Pluri had a negative return on equity of 493.74% and a negative net margin of 6,341.03%.

Pluri Company Profile

(Get Free Report)

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.

Featured Stories